Study to Investigate the Penetration of Rifabutin Into the Lung After

Status Recruiting

Clinical Trial Summary

Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100

Clinical Trial Description

This is a single center, open-label, monocentric, multiple IV dose, phase I study to investigate the penetration of rifabutin into the lung after multiple intravenous administrations of BV100 (rifabutin for infusion) in healthy participants. ;

Study Design

Related Conditions & MeSH terms

Bacterial Infections

Clinical Trial Details

NCT number	NCT05684705
Study type	Interventional
Source	BioVersys AG
Contact	Glenn Dale, PhD
Phone	0796998389
Email	glenn.dale@bioversys.com
Status	Recruiting
Phase	Phase 1
Start date	September 1, 2023
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03726216` - Xydalba Utilization Registry in France
Completed	`NCT03605498` - OR PathTrac (Tracking Intra-operative Bacterial Transmission)
Withdrawn	`NCT05269121` - Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections	Phase 1/Phase 2
Completed	`NCT02541695` - Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli	N/A
Recruiting	`NCT02074865` - Children's Antibiotic Resistant Infections in Low Income Countries	N/A
Completed	`NCT01932034` - Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software	N/A
Completed	`NCT01689207` - To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)	Phase 1
Completed	`NCT01412801` - Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings	Phase 2
Not yet recruiting	`NCT01159470` - The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children	N/A
Completed	`NCT00983255` - Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)	Phase 1
Completed	`NCT00678106` - Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections	Phase 1
Completed	`NCT00799591` - French Study In ICU Patients Treated With Tigecycline	N/A
Completed	`NCT01074775` - Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection	N/A
Completed	`NCT00478855` - Tazocin Intervention Study	Phase 4
Terminated	`NCT00431028` - Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery	Phase 1/Phase 2
Not yet recruiting	`NCT03634904` - Serum Ceftazidime Concentrations in Hemodialysis Patients	N/A
Recruiting	`NCT03858387` - PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients
Enrolling by invitation	`NCT04764058` - Efficacy and Safety of Colistin Based Antibiotic Therapy	Phase 1/Phase 2
Recruiting	`NCT06319235` - Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®	Phase 1/Phase 2
Completed	`NCT03332732` - VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers	Phase 1